Cancer Prevention

Surviving Pancreatic Cancer with Larisa Belote

Larisa Belote Owner of Step by Step Wellness and author of the new book Surviving Pancreatic Cancer joins eHealth Radio and the  Cancer Prevention & Nutrition Channels.
Listen to interview with host Eric Michaels & guest Larisa Belote discuss the following:Tell me about your book "Surviving Pancreatic Cancer".Why did you write this book? Did something or someone influence or inspire you here?Do you incorporate any of the therapies or treatments in your practice as a Holistic Nutritionist today that you describe in your book?What type of message do you want the listeners to walk away with today?
Duration: 14:16
Larisa Belote is an owner of Step by Step-Wellness.  She is a Certified Holistic Nutritionist, CHHC, AADP, who studied at the Institute for Integrative Nutrition and completed her training with some of the world's top health and wellness experts.  She is certified by the American Association of Drugless Practitioners and has obtained Continuing Education Units from Purchase College, State University of New York.
Larisa is dedicated in helping her clients find balance in all areas of their lives by making lifestyle changes that produce real and lasting results. By looking at how all areas of life are connected through mind, body and spirit, her clients develop a deeper understanding of the foods and lifestyle choices that work best for their bio-individuality that will improve their energy, balance, health and weight.  Larisa leads workshops on nutrition and offers one on one as well as group health coaching in person, telephone or skype.  Her office is located at 4 Bridge Plaza Drive, Manalapan NJ.
Larisa is also an author of a new book called Surviving Pancreatic Cancer.

Website: www.stepbystep-wellness.com

One in five Americans will develop skin cancer in this lifetime

Dr. Peter Katz a Board Certified Dermatologist at Dermatology Associates of Wisconsin who is knowledgeable in the latest treatment protocols for skin diseases and condition joins eHealth Radio and the Cancer Prevention, Dermatology and Skin Care Channels.
Listen to interview with host Eric Michaels and guest Dr. Peter Katz discuss the following: How did you get started in the field of medicine and what made you choose dermatology?What differentiates Dermatology Associates of Wisconsin from other dermatology practices in the region? It is Skin Cancer Prevention and Detection Month. Can you provide some tips that our listeners can do to better prepare themselves for the summer months ahead and not be a candidate for skin cancer? If you stayed out in the sun too long as a child, can you reverse the damage that has already been done? I read that Melanoma is the worst kind of skin cancer. What causes it and is there any way to detect it? For our dads that are listening, with Father’s Day coming up do you have any special advice for those dads concerned with their overall skin health?Does your practice accept insurance? 
Duration: 14:36
Dr. Katz is a Board Certified Dermatologist at Dermatology Associates of Wisconsin who is knowledgeable in the latest treatment protocols for skin diseases and conditions. He specifically works at the Appleton and New London, Wisconsin offices.
His professional areas of interest include early skin cancer detection and treatments of rosacea, eczema and atopic dermatitis, acne, psoriasis, vitiligo, warts, molluscum, skin allergies, rashes, dermatologic surgery for skin cancer and problematic growths, surgical treatment of rhinophyma and laser tattoo removal.
Dr. Katz has received numerous awards including: Alpha Omega Alpha Honor Society, MCW Honors in Medical research, MCW Merck Award for outstanding achievement in medical academics, MCW Brooker Award for outstanding achievement in pharmacology, University of Iowa Dermatology Chief Resident, NCAA Football div III 1st team Academic All-American and Wisconsin Intercollegiate Conference Scholar Athlete of the Year. 

Website: www.dermwisconsin.com | www.forefrontdermatology.com

New Advances in Diabetes Treatment: Insulin-Producing Cells That Could Replace Injections

Dr. Gerald Crabtree, Chief Operating Officer and Director at PharmaCyte Biotechnology, a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box joins eHealth Radio and the Diabetes and Health News Channels.
Listen to interview with host Eric Michaels and guest Dr. Gerald Crabtree discuss the following:In an effort to understand how the Melligen cells works, can you explain what happens to the pancreas in Type 1 diabetes?Why are liver cells such good candidates to replace the damaged cells in the pancreas?What have early lab trials shown?How does PharmaCyte’s Cell-in-the-Box help the melligen cells do their jobs?How will this technology help the lives of those patients living with Type 1 Diabetes?
Duration: 15:55
Dr. Gerald Crabtree is PharmaCyte’s Chief Operating Officer. Since 1985, Dr. Crabtree has been involved with various biopharmaceutical companies where he has alternatively supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, and research and review articles and served as project manager for development of major oncologic agents. He is a Member of the American Society of Clinical Oncology and also is a past member of research grant review committees for the National Institute of Health and the American Cancer Society. Dr. Crabtree established and directed, from inception, a department that monitored and coordinated the development of oncologic and immunologic drugs from initial discovery through regulatory approval in a major pharmaceutical company and served as project manager for the development of the anticancer agent, Taxol®.
Dr. Crabtree received his Ph.D. in Biochemistry from the University of Alberta, Edmonton, Alberta, Canada and has published over 80 articles in peer-reviewed journals. He is a National Cancer Institute of Canada Research Fellow. In addition, he served as Department Head of Molecular Pharmacology for the Nucleic Acid Research Institute, and prior to that as Associate Professor of Medicine with the Roger Williams Cancer Center at Brown University. Dr. Crabtree has also served as Director of Project Planning and Management (Oncology/Immunology) at Bristol-Myers Squibb and as Vice-President of Research and Development at ETEX Corporation.

Website: www.pharmacytebiotech.com

Personalized Chemotherapy with Dr. Robert Nagourney and Rational Therapeutics

Dr. Robert Nagourney, Founder and Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California, and a Clinical Professor, at University of California Irvine, Department of Obstetrics and Gynecology joins eHealth Radio and the Cancer Prevention Information Channel.
Listen to interview with host Eric Michaels & guest Dr. Robert Nagourney discuss the following:Tell us about your pioneering work in personalized chemotherapy and functional profiling.Is it possible to choose the most effective chemotherapy drugs before patients receive them?Why hasn’t this been more widely applied?Do you have published data to support your work?What do you think has made it possible for you to succeed where others have failed?Going forward, what are the implications of your ability to successfully conduct these studies?What is the best advice you can give to people who have been just diagnosed with cancer?
Duration: 10:24
Robert A. Nagourney, MD, is Medical and Laboratory Director at Rational Therapeutics, Inc., in Long Beach, California, and a Clinical Professor, University of California Irvine, Department of Obstetrics and Gynecology.  He is board certified in internal medicine, medical oncology, and hematology.
A native of Bridgeport, Connecticut, Dr. Nagourney completed undergraduate education at Boston University, earning a BA in Chemistry, Summa Cum Laude, Phi Beta Kappa with Distinction in Biochemistry.  He received his MD at McGill University in Montreal, Canada, where he was a University Scholar.  After completing his residency in Internal Medicine at the University of California, Irvine, Dr. Nagourney received fellowship training in Medical Oncology at Georgetown University in Washington, DC.  He went on to complete a second fellowship in hematology at the Scripps Institute in La Jolla, California, where he was the recipient of the Scripps Institute Young Investigator Award.
Dr. Nagourney went on to found Rational Therapeutics, a cancer research institute located in Long Beach, California, that has pioneered the development of “functional profiling” in human tumors.  The functional profiling platform uses human tumor microspheroids in primary culture to measure drug induced programmed cell death, both apoptotic and non-apoptotic. It has proven a robust method for the prediction of clinical response to therapy. Following its successful application to cytotoxic drugs and radiation, this platform has now been successfully applied in the development of novel compounds, drug combinations and to the study of signal transduction inhibitors and “targeted” agents.
With over 20 years experience in human tumor primary culture analyses, Dr. Nagourney has authored more than 100 manuscripts, book chapters and abstracts including publications in the Journal of Clinical Oncology, Gynecological Oncology and The Journal of National Cancer Institute. As co-investigator on national cooperative trials, Dr. Nagourney is recognized for the introduction of Platin/Gemcitabine doublets to the treatment of advanced ovarian and breast cancer. A frequently invited lecturer for numerous professional organizations and universities, Dr. Nagourney has served as a reviewer and on the editorial boards of several journals including Clinical Cancer Research, British Journal of Cancer, Gynecologic Oncology, Cancer Research and the Journal of Medicinal Food. Dr Nagourney resides in Long Beach, California with his wife and two sons.

Website: www.RationalTherapeutics.com

Why Colorado Patients are at a Higher Risk for Developing Melanoma than Most

Dr. Richard Asarch, who is board certified in dermatology and a fellow of the American College of Mohs Surgery with a full practice and medical spa in Denver, Colorado again joins eHealth Radio and the Cancer Prevention Channel.
On Tuesday, April 28th, 2015 the Melanoma Research Foundation will be honoring Dr. Asarch, with the MRF's Humanitarian Award. The MRF presents the Humanitarian Award to those in the local community who have committed to fighting melanoma through exemp-lary patient care, cutting-edged research and scientific leadership.
Listen to interview with host Eric Michaels & guest Dr. Richard Asarch discuss the following:What is Melanoma?What causes Melanoma?Can you explain Melanoma prevention and protection? Why are patients in Colorado at a higher risk for developing Melanoma? How is Melanoma detected & how is it diagnosed? You have performed over 30,000 Mohs surgeries. How does Mohs work to treat Melanoma?What are the top 3 pieces of advice you would give your patients about Melanoma and Skin Cancer?
Duration: 12:38
Dr. Richard Asarch, MD, PC heads the Asarch Center for Dermatology, Laser and Mohs Surgery in Denver, CO, and it’s accompanying state-of-the-art DermaSpa. Having spent over 35 years in practice evaluating and adopting the latest advances in medical and cosmetic dermatology, his experience and continued dedication to his patients and their overall health, Dr. Asarch is truly a leader in both the local and national medical community.
Considered an expert on melanoma and other skin cancers, Dr. Asarch is Double Board Certified in Dermatology and Dermatopathology and has successfully completed over 30,000 Mohs Surgeries for skin cancer removal.  Dr. Asarch introduced Mohs to the state of Colorado in 1977 after studying directly with Dr. Frederic Mohs, the founder of Mohs Surgery.
The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma. Committed to the support of medical research in finding effective treatments and eventually a cure for melanoma, the MRF also provides education about prevention, diagnosis and the treatment of melanoma.

Website: www.asarchcenter.com

Bouncing back from adversity with Josie Thomson

Josie Thomson who is a NeuroLeadership, Resilience & Change Expert, a Multi-Award Winning Coach, an International Speaker & Presenter, a two-time cancer survivor, and Lifestyle Author & Writer at JosieThomson.com joins eHealth Radio and the Personal Developement Channel.Listen to interview with host Eric Michaels & guest Josie Thomson discuss the following:Describe how you got to where you are today? What 'reinventions' occurred and how did you succeeded.How has your outlook on life changed?What do you do to embrace life more fully?What do you do when things don't go as planned?If you would share a final tip or one word that has grown in significance to you?
Duration: 8:40
Neuroleadership expert and acclaimed executive coach, Josie Thomson knows a thing or two about resilience. As a two-time cancer survivor, she is living proof that: more than education, more than experience, more than training, more than any one single factor, RESILIENCE determines who succeeds and who fails.
Her 28-year journey from being an executive in one of the world's largest mining companies, to twice surviving cancer, to juggling the priorities of being a single mum as well as an award winning coach & entrepreneur has given her a unique perspective on what it takes to succeed in life and leadership. And this has brought about her mission in life: to create resilient leaders and communities.
​A true storyteller with a passion for enhancing human performance, she shares her personal stories authentically from the heart, weaving them with her deep understanding of the brain to provide those true 'aha!' moments that motivate and inspire. Josie is a leading voice in building resilience capability for individuals, communities and organisations, to look with themselves and discover an empowered world beyond themselves. ​
Her presentation style has been described as a rare mix of engaging, interactive, informative and insightful. And her audiences appreciate that she makes the content real, providing them with practical strategies that can be confidently applied immediately.
​As a sought after speaker, Josie has shared the stage with top motivational speakers on the global circuit, speaking at many of the world's leading conferences, including: STADA, Mind & Its Potential, ICF Global, ICF Australasia, AITD, CPA Congress and many more.
On a more personal note, Josie is an Ambassador for Childhood Cancer Support, a not-for-profit group that supports families of kids receiving treatment for cancer. She lives in Brisbane with her two beautiful children, Kristen and Harrison.
Specialist Areas:
ResilienceChange Possibility MindsetNeuroLeadership Coaching​
Keynotes, workshops and/or half and full day training programs:
The Neuroscience of LeadershipThe Neuroscience of ResilienceHandling Cancer in the WorkplaceEmbracing a Possibility Mindset for Creativity & Innovative SolutionsRewiring the Brain for ChangeChange Your Mind, Change Your LifeMindfulness, The Brain & BusinessThe Neuroscience of Effective Learning Cultures

Website: www.josiethomson.com

Additional option for earlier detection of breast cancer especially for dense breasted patients

Danna F. Grear, MD a Clinical Breast Radiologist who has been providing imaging services in Northwest Arkansas since 1989 joins eHealth Radio and the Cancer Prevention and Technology Channels.
Listen to interview with host Eric Michaels & guest Dr. Danna F. Grear discuss the following:What convinced you to offer ultrasound breast screening to your patients and describe the patient type who should have this examination?What is the SonoCiné AWBUS™ technology and why did you choose to offer this breast screening examination?How is ultrasound different than mammography and why not use ultrasound on all women instead of mammography? Why don’t all breast facilities offer this type of screening for their dense breasted patients?I understand that there are Breast Density Information Laws that are forcing imaging facilities to tell women if they have dense breast tissue.  Are they working and how do you feel about this?Tell us about the new insurance codes for ultrasound breast screening. What does this mean for dense breasted women and the facilities who offer this supplemental screening?What is your advice to women for protecting their breast health?
Duration: 16:53
Danna F. Grear, MD is a Clinical Breast Radiologist who has been providing imaging services in Northwest Arkansas since 1989. Dr. Grear, along with Dr. Kevin Pope developed the first image guided breast biopsy program in Northwest Arkansas in 1995. She and Dr. Kevin Pope founded The Breast Center, a MANA Clinic, as the first independent, dedicated breast center in Arkansas in 2003.
Grear is board certified in Radiology by the American Board of Radiology. She completed a Diagnostic Radiology Residency at University Texas Medical Branch in Galveston, Texas. She was instrumental in the organization of the Multidisciplinary Breast Conference at Washington Regional Medical Center and currently serves on the Credentials Committee. Grear has been a member of the Mammography Clinical Image Review Committee for the Arkansas Department of Health for over 10 years. She is a current member of the Society of Breast Imaging and the American Society of Breast Disease.
Grear serves on the board for the Susan G. Komen for the Cure Ozark Affiliate and has been an active volunteer since it’s inception in 1998. She received the Komen Cameo award in 2007, a national award recognizing volunteerism. She is actively involved in the community with organizations such as Womenade. Grear serves on the MANA Charitable Fund Board and was key in creating the Murray T. Harris Allied Healthcare Scholarship program.

Websites: www.mana.md | www.sonocine.com

A new advanced technology to help find early stage breast cancer

Dr. David Weintritt, a board certified breast surgeon and Founder of the National Breast Center with the goal of improving access to care, technology for breast cancer screening and treatment, and giving women in the Washington Metropolitan Area the options they deserve joins eHealth Radio and the Cancer Prevention and Technology Channels.
Listen to interview with host Eric Michaels & guest Dr. David Weintritt discuss the following:What convinced you to offer ultrasound breast screening to your patients and describe the patient type who should have this examination?What is the SonoCiné AWBUS™ technology and why did you choose to offer this breast screening examination?  How is ultrasound different than mammography and why not use ultrasound on all women instead of mammography? Why don’t all breast facilities offer this type of screening for their dense breasted patients?I understand that there are Breast Density Information Laws that are forcing imaging facilities to tell women if they have dense breast tissue.  Are they working and how do you feel about this?Tell us about the new insurance codes for ultrasound breast screening. What does this mean for dense breasted women and the facilities who offer this supplemental screening?What is your advice to women for protecting their breast health?
Duration: 13:49
Dr. David Weintritt is a board certified breast surgeon and founder of the National Breast Center. Dr. Weintritt completed his college and medical education at the University of Florida. After graduation, he served as a general surgeon in the Air Force at Andrews Air Force Base.
During his tenure as an Air Force surgeon, he was able to work with Bethesda Naval Hospital in offering sentinel node biopsy, a procedure now standard in breast cancer surgery. From there, he entered into private practice in Annapolis, MD where he worked in the hospital’s new breast center; gaining experience in breast ultrasound and minimally invasive approaches for breast disease management.
In 2003, Dr. Weintritt opened his own practice in Alexandria, VA. He started a program for sentinel node biopsy and was the first to bring partial breast radiation to the area.
In 2010, Dr. Weintritt was named a director of the INOVA Mount Vernon Breast Care Institute. He is consistently the highest volume breast cancer surgeon in the INOVA system.
In 2012 Dr. Weintritt founded the National Breast Center to continue raising awareness of new treatment options and to expand services available for breast cancer patients.
In 2014 Dr. Weintritt founded the National Breast Center Foundation with the goal of improving access to care, technology for breast cancer screening and treatment, and giving women in the Washington Metropolitan Area the options they deserve.

Website: www.nationalbreastcenter.com | www.sonocine.com

Palmetto Health Breast Center, offering ultrasound breast screening to their patients

Dr. Shawn Conwell, the Professional Director of Palmetto Health Breast Center in Richland, South Carolina and a Partner at Pitts Radiology joins eHealth Radio and the Cancer Prevention and Technology Channels. Listen to interview with host Eric Michaels & guest Dr. Shawn Conwell discuss the following:What convinced you to offer ultrasound breast screening to your patients and describe the patient type who should have this examination?What is the SonoCiné AWBUS™ technology and why did you choose to offer this breast screening examination?  How is ultrasound different than mammography and why not use ultrasound on all women instead of mammography? Why don’t all breast facilities offer this type of screening for their dense breasted patients?I understand that there are Breast Density Information Laws that are forcing imaging facilities to tell women if they have dense breast tissue.  Are they working and how do you feel about this?Tell us about the new insurance codes for ultrasound breast screening. What does this mean for dense breasted women and the facilities who offer this supplemental screening?What is your advice to women for protecting their breast health?
Duration: 15:39
Dr. W. Shawn Conwell is the Professional Director of Palmetto Health Breast Center in Richland, South Carolina and a Partner at Pitts Radiology. For over 15 years, Dr. Conwell has been helping to empower patients to get control of their health and no various medical screening options that are available to them. He is a highly coveted ‘Breast Specialist’ who graduated from Medicine College of Georgia School Of Medicine, Augusta Georgia and a residency training of Diagnostic Radiology at Metrohealth Medicine Center. He also has completed extensive post graduate training work at Women’s Imaging Fellowship, Magee Women’s Hospital, Case Western Reserve and MetroHealth Medical.
Dr. Conwell belongs to the following professional societies: American College of Radiology, Society of Breast Imaging, American Roentgen Ray Society, Radiological Society of North America and American Association for Women Radiologists. He has received numerous awards including the 2005 American College of Radiology Moorefield Fellow for Economics and Health Policy, the 2004 Resident of the Year and the 2000 Humanism in Medicine Award; Awarded by the Health Care Foundation of New Jersey. 

Websites: www.palmettohealth.org | www.sonocine.com

SonoCiné AWBUS Technology, detecting and diagnosing breast cancer in dense-breasted women

Dr. Kevin Kelly, one of the country's leading authorities on breast cancer detection and Co-Founder of SonoCiné, Inc. joins eHealth Radio and the Cancer Prevention & Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Kevin Kelly discuss the following:Describe to our listeners what SonoCiné AWBUS is and what does AWBUS stand for?What makes SonoCiné AWBUS™ technology different?How does it work?I understand this exam is for women with dense breast tissue. What is the difference between dense-breast tissue and fatty-breast tissue?Recently it seems there has been states passing a law that are Dense Breast Tissue notification laws. What are those laws and how do they impact what your team is trying to do? Do you see ultrasound one day replacing mammography? Why has every doctor not adopted the technology yet? Where can women go to get more information or to find a doctor that performs the SonoCiné exam? 
Duration: 17:05
Dr. Kevin M. Kelly is Chief Executive Officer, Chairman of the Board, Chief Medical Officer and Co-Founder of SonoCiné, Inc. He is also Medical Director of the Breast Ultrasound Center in Pasadena, CA.
Dr. Kelly is one of the country's leading authorities on breast cancer detection in women with dense-breast tissue and women with implants. He was Director of Breast Imaging at the Huntington Memorial Hospital and the Huntington Hill Breast Center, Pasadena, CA for 20 years before opening a private practice in Pasadena, CA.   His breakthrough clinical study on breast cancer detection using ultrasound in radiographically dense breasts was published in 2009 in European Radiology (one of the most prestigious radiology journals in the world).  This pivotal work has since been cited in more than 100 other scientific publications around the world.
Dr. Kelly's lifelong commitment to early breast cancer detection began with clinical research into the limitations of mammography in detecting and diagnosing breast cancer in dense-breasted women.  In 1997, he co-founded SonoCiné, Inc., to develop and clinically validate what is now known as the SonoCiné AWBUS™ technology.  Working with other leading breast imaging radiologists, more than 6,000 clinical results demonstrated a 100% increase in detection (over mammography) of invasive cancers smaller than 1cm in diameter.  With this success, he moved to launch SonoCiné, Inc.
Dr. Kelly earned his Bachelor of Science degree at Georgetown University.  He completed his Medical Degree, internship and first two years of residency at St. Louis University and the St. Louis University Service of St. Louis City Hospital.  He was the Leo G. Rigler Center Research Fellow at UCLA from 1973 to 1974 and finished his final year of residency at the Wadsworth Veterans Administration Hospital in Los Angeles.
In addition to his many professional credentials in the field of radiology, Dr. Kelly was also a Lt. Commander in the U.S. Public Health Service.

Website: www.sonocine.com